TW201620925A - 用於製備人類血漿蛋白質的方法 - Google Patents
用於製備人類血漿蛋白質的方法 Download PDFInfo
- Publication number
- TW201620925A TW201620925A TW104107803A TW104107803A TW201620925A TW 201620925 A TW201620925 A TW 201620925A TW 104107803 A TW104107803 A TW 104107803A TW 104107803 A TW104107803 A TW 104107803A TW 201620925 A TW201620925 A TW 201620925A
- Authority
- TW
- Taiwan
- Prior art keywords
- plasma
- column
- chromatography
- immunoglobulin
- affinity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/363—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1451997A FR3018450B1 (fr) | 2014-03-11 | 2014-03-11 | Procede de preparation de proteines plasmatiques humaines |
Publications (1)
Publication Number | Publication Date |
---|---|
TW201620925A true TW201620925A (zh) | 2016-06-16 |
Family
ID=51210517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW104107803A TW201620925A (zh) | 2014-03-11 | 2015-03-11 | 用於製備人類血漿蛋白質的方法 |
Country Status (13)
Country | Link |
---|---|
US (1) | US20170073396A1 (ja) |
EP (1) | EP3116527B1 (ja) |
JP (1) | JP2017508759A (ja) |
KR (1) | KR20160130495A (ja) |
CN (1) | CN106103473A (ja) |
AU (1) | AU2015228649A1 (ja) |
CA (1) | CA2942203A1 (ja) |
ES (1) | ES2759259T3 (ja) |
FR (1) | FR3018450B1 (ja) |
IL (1) | IL247508A0 (ja) |
MX (1) | MX2016011641A (ja) |
TW (1) | TW201620925A (ja) |
WO (1) | WO2015136217A1 (ja) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3018450B1 (fr) | 2014-03-11 | 2016-04-15 | Lab Francais Du Fractionnement | Procede de preparation de proteines plasmatiques humaines |
WO2017066683A1 (en) * | 2015-10-15 | 2017-04-20 | Plasma Technologies, Llc | Methods for extracting proteins from blood plasma |
US20200325169A1 (en) * | 2016-04-05 | 2020-10-15 | Haemonetics Corporation | Methods and Devices for the Enrichment of Immunoglobulin from Blood |
CN109689088A (zh) * | 2016-07-06 | 2019-04-26 | 法国血液分割暨生化制品实验室 | 稳定的液体纤维蛋白原 |
FR3053592B1 (fr) * | 2016-07-06 | 2020-05-29 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Fibrinogene liquide stable |
EP3275897A1 (en) | 2016-07-27 | 2018-01-31 | Biotest AG | Process for preparing immunoglobulin compositions |
EP3491136A1 (en) | 2016-07-28 | 2019-06-05 | Laboratoire Francais du Fractionnement et des Biotechnologies Societe Anonyme | Anti- immunoglobulin g aptamers and uses thereof |
FR3061020B1 (fr) | 2016-12-22 | 2019-05-17 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Composition de fibrinogene humain |
ES2906118T3 (es) | 2016-12-22 | 2022-04-13 | Km Biologics Co Ltd | Método cromatográfico para recolectar factor VII de coagulación sanguínea con alto rendimiento |
US11427613B2 (en) * | 2017-03-16 | 2022-08-30 | Evolve Biologics Inc. | Method for purification of albumin |
CN107216384A (zh) * | 2017-05-11 | 2017-09-29 | 深圳市卫光生物制品股份有限公司 | 一种人血浆转铁蛋白分离纯化的方法 |
CN107033237B (zh) * | 2017-05-11 | 2021-07-20 | 深圳市卫光生物制品股份有限公司 | 一种人血浆载脂蛋白a-i的分离纯化方法 |
CN107827974B (zh) * | 2017-11-10 | 2021-01-01 | 中国科学院过程工程研究所 | 一种人纤维蛋白原的制备方法 |
CN108101981B (zh) * | 2018-01-15 | 2019-06-04 | 四川远大蜀阳药业有限责任公司 | 一种静注免疫球蛋白的生产工艺 |
FR3081328B1 (fr) * | 2018-05-24 | 2021-01-01 | Lab Francais Du Fractionnement | Composition d'immunoglobulines humaines concentrees |
FR3090321B1 (fr) * | 2018-12-21 | 2023-07-14 | Lab Francais Du Fractionnement | Procédé de filtration du fibrinogène |
CN110314414B (zh) * | 2019-07-23 | 2021-10-19 | 宝锐生物科技泰州有限公司 | 凝血因子xiii的分离纯化方法及其应用 |
US11833279B2 (en) * | 2021-06-11 | 2023-12-05 | Astaria Global, LLC | System and method for isolating alpha 2M molecules |
CN113754757B (zh) * | 2021-07-01 | 2024-06-14 | 华兰生物工程股份有限公司 | 一种人纤维蛋白原的制备方法 |
AU2022317368A1 (en) * | 2021-07-29 | 2024-02-22 | Csl Behring Ag | Method of purifying immunoglobulin g and uses thereof |
CN113563457B (zh) * | 2021-08-20 | 2023-02-24 | 华兰生物工程股份有限公司 | 一种同时制备人纤维蛋白原、凝血因子ⅷ和纤溶酶原的方法 |
CN114835801B (zh) * | 2022-06-20 | 2023-09-22 | 华润博雅生物制药集团股份有限公司 | 一种c1酯酶抑制剂及其制备方法 |
CN117069836A (zh) * | 2023-09-22 | 2023-11-17 | 武汉中生毓晋生物医药有限责任公司 | 一种抗人t细胞兔免疫球蛋白的制备方法 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1055825A (fr) | 1951-02-20 | 1954-02-22 | Perfectionnement aux montures de lunettes optiques, solaires et faces supplémentaires solaires | |
BE517346A (ja) | 1952-04-21 | |||
CN1072419A (zh) * | 1991-11-20 | 1993-05-26 | 中国科学院大连化学物理研究所 | 径向色谱柱用离子交换介质的合成 |
FR2706466B1 (fr) | 1993-06-14 | 1995-08-25 | Aetsrn | Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré. |
DK0764658T3 (da) * | 1995-09-22 | 2002-04-22 | Zlb Bioplasma Ag | Fremgangsmåde til fremstilling af immunoglobuliner ud fra fraktioner, som opstår ved fraktionering af blodplasma fra mennesker |
ES2527915T3 (es) * | 1998-06-09 | 2015-02-02 | Csl Behring Ag | Producto de inmunoglobulina G (IgG) líquido |
KR100501263B1 (ko) * | 1998-06-09 | 2005-07-18 | 스태튼스 세룸 인스티튜트 | 정맥 주사용 면역글로불린의 제조 방법 및 그 외의 면역글로불린 제품 |
DE19858892A1 (de) * | 1998-12-19 | 2000-06-21 | Merck Patent Gmbh | Kontinuierliches Verfahren zur Trennung von Stoffen nach Molekülgröße |
SE0001128D0 (sv) * | 2000-03-30 | 2000-03-30 | Amersham Pharm Biotech Ab | A method of producing IgG |
FR2824568B1 (fr) | 2001-05-11 | 2004-04-09 | Lab Francais Du Fractionnement | Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique |
WO2006023831A2 (en) | 2004-08-20 | 2006-03-02 | Prometic Biosciences Ltd. | Sequential protein isolation and purification schemes by affinity chromatography |
EP1775001A1 (en) * | 2005-10-13 | 2007-04-18 | Xendo Holding B.V. | Device for chromatographic separations |
FR2895263B1 (fr) * | 2005-12-26 | 2008-05-30 | Lab Francais Du Fractionnement | Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives |
WO2007144476A1 (fr) * | 2006-06-16 | 2007-12-21 | Groupe Novasep | Procede de separation sequence multicolonnes |
WO2008153472A1 (en) | 2007-06-15 | 2008-12-18 | Ge Healthcare Bio-Sciences Ab | Chromatography method |
FR2929533B1 (fr) | 2008-04-03 | 2010-04-30 | Novasep | Procede de separation multicolonnes a gradient. |
FR2939667B1 (fr) * | 2008-12-17 | 2012-01-27 | Fractionnement Et Des Biotechonologies Lab Franc | Composition d'immunoglobine g comme medicament pour le traitement de l'ictere neonatal par incompatibilite foetomaternelle dans le systeme abo |
FR2942233B1 (fr) * | 2009-02-19 | 2015-03-13 | Lfb Biotechnologies | Moyens pour la purification d'une proteine du plasma sanguin, et procedes pour sa mise en oeuvre |
FR2970003B1 (fr) | 2010-12-30 | 2013-01-25 | Lfb Biotechnologies | Procede d'immobilisation d'acides nucleiques |
FR2977893B1 (fr) | 2011-07-11 | 2015-02-20 | Lab Francais Du Fractionnement | Procede de preparation d'un concentre d'immunoglobulines polyvalentes |
EP2656892A1 (en) | 2012-04-23 | 2013-10-30 | Merck Patent GmbH | Chromatography method |
FR3018450B1 (fr) | 2014-03-11 | 2016-04-15 | Lab Francais Du Fractionnement | Procede de preparation de proteines plasmatiques humaines |
-
2014
- 2014-03-11 FR FR1451997A patent/FR3018450B1/fr active Active
-
2015
- 2015-03-10 US US15/125,483 patent/US20170073396A1/en not_active Abandoned
- 2015-03-10 EP EP15717016.8A patent/EP3116527B1/fr not_active Revoked
- 2015-03-10 KR KR1020167028103A patent/KR20160130495A/ko unknown
- 2015-03-10 JP JP2016556862A patent/JP2017508759A/ja active Pending
- 2015-03-10 CN CN201580012945.8A patent/CN106103473A/zh active Pending
- 2015-03-10 AU AU2015228649A patent/AU2015228649A1/en not_active Abandoned
- 2015-03-10 WO PCT/FR2015/050598 patent/WO2015136217A1/fr active Application Filing
- 2015-03-10 ES ES15717016T patent/ES2759259T3/es active Active
- 2015-03-10 CA CA2942203A patent/CA2942203A1/fr not_active Abandoned
- 2015-03-10 MX MX2016011641A patent/MX2016011641A/es unknown
- 2015-03-11 TW TW104107803A patent/TW201620925A/zh unknown
-
2016
- 2016-08-28 IL IL247508A patent/IL247508A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2017508759A (ja) | 2017-03-30 |
EP3116527A1 (fr) | 2017-01-18 |
MX2016011641A (es) | 2016-10-31 |
IL247508A0 (en) | 2016-11-30 |
KR20160130495A (ko) | 2016-11-11 |
ES2759259T3 (es) | 2020-05-08 |
AU2015228649A1 (en) | 2016-09-15 |
EP3116527B1 (fr) | 2019-09-04 |
US20170073396A1 (en) | 2017-03-16 |
CA2942203A1 (fr) | 2015-09-17 |
WO2015136217A1 (fr) | 2015-09-17 |
FR3018450A1 (fr) | 2015-09-18 |
CN106103473A (zh) | 2016-11-09 |
FR3018450B1 (fr) | 2016-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW201620925A (zh) | 用於製備人類血漿蛋白質的方法 | |
Marichal‐Gallardo et al. | State‐of‐the‐art in downstream processing of monoclonal antibodies: Process trends in design and validation | |
Lihme et al. | A novel core fractionation process of human plasma by expanded bed adsorption chromatography | |
US9663553B2 (en) | Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma | |
AU2009270723A1 (en) | Method of preparing alpha-1 proteinase inhibitor | |
JP6132839B2 (ja) | 多価免疫グロブリン濃縮物の製造方法 | |
Menegatti et al. | Purification of polyclonal antibodies from C ohn fraction II+ III, skim milk, and whey by affinity chromatography using a hexamer peptide ligand | |
ES2736283T3 (es) | Procedimientos para aislar hemoderivados a partir de un material hemoderivado empobrecido en proteína interalfainhibidora | |
US9403899B2 (en) | Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition | |
JP2016199586A (ja) | 熱処理を通じてIgG組成物を得るための方法 | |
US20210363179A1 (en) | Method for removing fxi when purifying plasma proteins | |
Hofbauer et al. | Affinity chromatography for purification of IgG from human plasma | |
TWI526214B (zh) | 缺乏一種以上致血栓因子的血漿製品之製備方法 | |
KR20240040107A (ko) | 면역글로불린 g를 정제하는 방법 및 이의 용도 | |
CN117769570A (zh) | 纯化免疫球蛋白g的方法及其用途 | |
AU2015268579A1 (en) | Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition | |
KR20230148961A (ko) | 면역글로불린 정제방법 |